🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Fruquintinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fruquintinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cep
3 shared targets
hematoxylin
2 shared targets
semaxanib
3 shared targets
gw843682x
2 shared targets
lucitanib
3 shared targets
gw770249x
2 shared targets
vatalanib
3 shared targets
pexidartinib
2 shared targets
maleimide
3 shared targets
mk
3 shared targets
Loading evidence profile...

This evidence profile for Fruquintinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.